Jubilant Radiopharma Introduces RUBY Mobile Solutions After FDA Approval, Expanding Provider and Patient Access to PET Imaging

Partner News | Published: Thursday, July 6, 2023

---

The Food & Drug Administration (FDA) has approved Rubidium Elution system and RUBY-FILL^® (Rubidium Rb82 generator) in mobile settings, expanding access to providers and patients.  

RUBY-FILL is used for cardiac PET imaging under rest or pharmacologic stress conditions to evaluate regional myocardial perfusion in patients with suspected or existing coronary artery disease.

Since the FDA approval of RUBY-FILL in 2016, Jubilant Radiopharma has partnered with health care providers across the U.S. to establish and grow cardiac PET programs. Typically, cardiac PET is performed in larger hospitals, outpatient programs and physician offices whose patient volumes can support a full time cardiac PET program. This new mobile solution will enable the use of cardiac PET in smaller community hospitals, in rural settings, and in areas where a full time cardiac PET program may not be warranted.

Jubilant Radiopharma is committed to offering this imaging modality in smaller settings, thereby increasing patient access to the benefits of cardiac PET imaging.

RUBY Mobile Solutions allows you, our customer, the ability to:

• Start a cardiac PET program on a part-time basis
• Experience first-hand the value  that RUBY-FILL^® (Rubidium Rb 82 Generator) and the RUBY Rubidium Elution System can bring to your practice
• Determine how cardiac PET with RUBY-FILL  will fit into a broader program for your patients in the future

To learn more, visit https://www.draximage.com/products/USA/ruby-fill-(rubidium-rb-82-generator)-and-elution-system.

« Back